Authors:
EECKHOUDT SL
DESAGER JP
HORSMANS Y
DEWINNE AJ
VERBEECK RK
Citation: Sl. Eeckhoudt et al., SENSITIVE ASSAY FOR MIDAZOLAM AND ITS METABOLITE 1'-HYDROXYMIDAZOLAM IN HUMAN PLASMA BY CAPILLARY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 710(1-2), 1998, pp. 165-171
Authors:
BALLIGAND JL
BRICHARD SM
BRICHARD V
DESAGER JP
LAMBERT M
Citation: Jl. Balligand et al., HYPOLEPTINEMIA IN PATIENTS WITH ANOREXIA-NERVOSA - LOSS OF CIRCADIAN-RHYTHM AND UNRESPONSIVENESS TO SHORT-TERM REFEEDING, European journal of endocrinology, 138(4), 1998, pp. 415-420
Authors:
LECLERCQ I
HORSMANS Y
DESAGER JP
DELZENNE N
GEUBEL AP
Citation: I. Leclercq et al., REDUCTION IN HEPATIC CYTOCHROME-P-450 IS CORRELATED TO THE DEGREE OF LIVER FAT-CONTENT IN ANIMAL-MODELS OF STEATOSIS IN THE ABSENCE OF INFLAMMATION, Journal of hepatology, 28(3), 1998, pp. 410-416
Authors:
DESCAMPS O
HONDEKIJN JC
GODRIE T
DESAGER JP
HELLER FR
Citation: O. Descamps et al., SINGLE DAILY ORAL DOSE OF GEMFIBROZIL REDUCES POSTPRANDIAL HYPERLIPIDEMIA IN HYPERLIPIDEMIC PATIENTS, Current therapeutic research, 59(8), 1998, pp. 545-555
Citation: I. Leclercq et al., INHIBITION OF CHLORZOXAZONE METABOLISM, A CLINICAL PROBE FOR CYP2E1, BY A SINGLE INGESTION OF WATERCRESS, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 144-149
Citation: P. Durez et al., INTRAVENOUS LOADING DOSE OF AZATHIOPRINE (AZA) IN ACTIVE RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 41(9), 1998, pp. 726-726
Authors:
HORSMANS Y
VANDENBERGE V
BOUCKAERT A
DESAGER JP
Citation: Y. Horsmans et al., PHENYTOIN HYDROXYLATION IN A HEALTHY CAUCASIAN POPULATION - BIMODAL DISTRIBUTION OF HYDROXYPHENYTOIN URINARY-EXCRETION, Pharmacology & toxicology, 81(6), 1997, pp. 276-279
Authors:
HORSMANS Y
SOLBREUX PM
DAENENS C
DESAGER JP
GEUBEL AP
Citation: Y. Horsmans et al., LACTULOSE IMPROVES PSYCHOMETRIC TESTING IN CIRRHOTIC-PATIENTS WITH SUBCLINICAL ENCEPHALOPATHY, Alimentary pharmacology & therapeutics, 11(1), 1997, pp. 165-170
Authors:
HORSMANS Y
SALIEZ A
VANDENBERGE V
DESAGER JP
GEUBEL AP
PAUWELS S
LAMBOTTE L
Citation: Y. Horsmans et al., C-14 PROPOXYPHENE DEMETHYLATION IN THE RAT - AN EXAMPLE OF DIFFERENCES BETWEEN LIVER AND INTESTINAL DRUG-PRESYSTEMIC METABOLISM, Drug metabolism and disposition, 25(11), 1997, pp. 1257-1259
Authors:
SPICAK V
DAB I
HULHOVEN R
DESAGER JP
KLANOVA M
DELONGUEVILLE M
HARVENGT C
Citation: V. Spicak et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS AND TODDLERS, Clinical pharmacology and therapeutics, 61(3), 1997, pp. 325-330
Authors:
LECLERCQ I
DESAGER JP
VANDENPLAS C
HORSMANS Y
Citation: I. Leclercq et al., FAST DETERMINATION OF LOW-LEVEL CYTOCHROME-P-450 1A1 ACTIVITY BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE OR VISIBLE ABSORBENCY DETECTION, Journal of chromatography B. Biomedical applications, 681(2), 1996, pp. 227-232
Citation: Y. Horsmans et al., RELATIONSHIP BETWEEN MEPHENYTOIN, PHENYTOIN AND TOLBUTAMIDE HYDROXYLATIONS IN HEALTHY AFRICAN SUBJECTS, Pharmacology & toxicology, 78(2), 1996, pp. 86-88
Citation: Jp. Desager et Y. Horsmans, CLINICAL PHARMACOKINETICS OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE INHIBITORS, Clinical pharmacokinetics, 31(5), 1996, pp. 348-371
Authors:
LECLERCQ I
HORSMANS Y
DESAGER JP
PAUWELS S
GEUBEL AP
Citation: I. Leclercq et al., INFLUENCE OF DIET ON LIVER VOLUME AND CYTOCHROME-P-450 (CYP) ACTIVITIES IN HUMAN NONALCOHOLIC FATTY LIVER, Hepatology, 24(4), 1996, pp. 737-737
Authors:
LECLERCQ I
HORSMANS Y
DESAGER JP
DELZENNE N
GEUBEL AP
Citation: I. Leclercq et al., REDUCTION IN CYP ACTIVITIES IS CORRELATED TO THE DEGREE OF FAT LIVER CONTENT IN 2 ANIMAL-MODELS OF NUTRITIONAL STEATOSIS, Hepatology, 24(4), 1996, pp. 738-738
Authors:
DESAGER JP
HORSMANS Y
VANDENPLAS C
HARVENGT C
Citation: Jp. Desager et al., PHARMACODYNAMIC ACTIVITY OF LIPOPROTEIN-LIPASE AND HEPATIC LIPASE, AND PHARMACOKINETIC PARAMETERS MEASURED IN NORMOLIPIDEMIC SUBJECTS RECEIVING CIPROFIBRATE (100 OR 200 MG DAY) OR MICRONIZED FENOFIBRATE (200 MG/DAY) THERAPY FOR 23 DAYS/, Atherosclerosis, 124, 1996, pp. 65-73
Citation: P. Lijnen et al., CHANGES IN PLASMA-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH PRAVASTATIN, Journal of human hypertension, 9(7), 1995, pp. 557-564
Citation: Jp. Desager et Y. Horsmans, PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS OF H-1-ANTIHISTAMINES, Clinical pharmacokinetics, 28(5), 1995, pp. 419-432
Authors:
HORSMANS Y
SALIEZ A
VANDENBERGE V
DESAGER JP
GEUBEL AP
PAUWELS S
LAMBOTTE L
Citation: Y. Horsmans et al., LIVER AND INTESTINAL PROPOXYPHENE METABOLISMS - AN EXAMPLE OF DISCREPANCY IN DRUG PRE-SYSTEMIC BIOTRANSFORMATION IN THE RAT, Hepatology, 22(4), 1995, pp. 561-561
Authors:
SPICAK V
KLANOVA M
HULHOVEN R
DESAGER JP
DELONGUEVILLE M
HARVENGT C
Citation: V. Spicak et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CETIRIZINE IN INFANTS, Journal of allergy and clinical immunology, 95(1), 1995, pp. 197-197
Authors:
FIORDALISO M
KOK N
DESAGER JP
GOETHALS F
DEBOYSER D
ROBERFROID M
DELZENNE N
Citation: M. Fiordaliso et al., DIETARY OLIGOFRUCTOSE LOWERS TRIGLYCERIDES, PHOSPHOLIPIDS AND CHOLESTEROL IN SERUM AND VERY-LOW-DENSITY LIPOPROTEINS OF RATS, Lipids, 30(2), 1995, pp. 163-167
Authors:
HELLER FR
PARFONRY A
DESCAMPS O
DESAGER JP
HARVENGT C
Citation: Fr. Heller et al., EFFECTS OF GEMFIBROZIL ON PLASMA-LIPOPROTEINS, PLASMA ACTIVITIES OF HEPATIC-ENZYMES, AND HEMOSTATIC VARIABLES IN HYPERTRIGLYCERIDEMIC PATIENTS, Current therapeutic research, 56(6), 1995, pp. 597-606
Authors:
HORSMANS Y
DESAGER JP
DAENENS C
HARVENGT C
GEUBEL AP
Citation: Y. Horsmans et al., D-PROPOXYPHENE AND NORPROPOXYPHENE KINETICS AFTER THE ORAL-ADMINISTRATION OF D-PROPOXYPHENE - A NEW APPROACH TO LIVER-FUNCTION, Journal of hepatology, 21(3), 1994, pp. 283-291